Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours

Clinical Radiology

Volumn 64, Issue 4, 2009, Pages 362-367

  Sohaib, S A ^a   Koh, D M ^a   Barbachano, Y ^b   Parikh, J ^a   Husband, J E S ^a   Dearnaley, D P ^a   Horwich, A ^a   Huddart, R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IOHEXOL;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GERM CELL TUMOR; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGIST; RETROPERITONEAL CANCER; STANDARD;

ADOLESCENT; ADULT; HUMANS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROPERITONEAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 60949099473     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2008.10.011     Document Type: Article

References (14)

1. Huddart R.A., Norman A., Shahidi M., et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21 (2003) 1513-1523
2. Travis L.B., Fossa S.D., Schonfeld S.J., et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97 (2005) 1354-1365
3. Sohaib S.A., and Husband J. Surveillance in testicular cancer: who, when, what and how?. Cancer Imaging 7 (2007) 145-147
4. van As N.J., Gilbert D.C., Money-Kyrle J., et al. Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer 98 (2008) 1894-1902
5. Hall E.J., and Brenner D.J. Cancer risks from diagnostic radiology. Br J Radiol 81 (2008) 362-378
6. White P.M., Howard G.C., Best J.J., and Wright A.R. The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumours. Clin Radiol 52 (1997) 124-129
7. Rustin G.J., Mead G.M., Stenning S.P., et al. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197-the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 25 (2007) 1310-1315
8. Harvey M.L., Geldart T.R., Duell R., Mead G.M., and Tung K. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer-a necessary risk?. Ann.Oncol 13 (2002) 237-242
9. Ellis J.H., Bies J.R., Kopecky K.K., Klatte E.C., Rowland R.G., and Donohue J.P. Comparison of NMR and CT imaging in the evaluation of metastatic retroperitoneal lymphadenopathy from testicular carcinoma. J Comput Assist Tomogr 8 (1984) 709-719
10. Hogeboom W.R., Hoekstra H.J., Mooyaart E.L., et al. The role of magnetic resonance imaging and computed tomography in the treatment evaluation of retroperitoneal lymph-node metastases of non-seminomatous testicular tumors. Eur J Radiol 13 (1991) 31-36
11. Koh D.M., Hughes M., and Husband J.E. Cross-sectional imaging of nodal metastases in the abdomen and pelvis. Abdom Imaging 31 (2006) 632-643
12. Krege S., Beyer J., Souchon R., et al. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: a Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I. Eur Urol 53 (2008) 478-496
13. Loughrey G.J., Carrington B.M., Anderson H., Dobson M.J., and Lo Ying Ping F. The value of specialist oncological radiology review of cross-sectional imaging. Clin Radiol 54 (1999) 149-154 discussion 154-5
14. Gollub M.J., Panicek D.M., Bach A.M., Penalver A., and Castellino R.A. Clinical importance of reinterpretation of body CT scans obtained elsewhere in patients referred for care at a tertiary cancer center. Radiology 210 (1999) 109-112